Tilray Brands (TLRY) Amortizatization of Intangibles (2019 - 2026)
Tilray Brands (TLRY) reported Amortizatization of Intangibles of $2.0 million for Q1 2026, down 27.22% on a YoY basis from $2.8 million in Q1 2025, and up 1.26% quarter-over-quarter from $2.0 million in Q4 2025.
Tilray Brands (TLRY) Amortizatization of Intangibles (2019 - 2026) Analysis & Trends
Tilray Brands has reported Amortizatization of Intangibles for 7 years, with the latest figure at $2.0 million in Q1 2026.
- For the quarter ending Q1 2026, Amortizatization of Intangibles fell 27.22% year-over-year to $2.0 million; the trailing twelve-month figure through Feb 2026 stood at -$69.0 million (down 59.6% YoY), and the FY2025 full-year result was $10.9 million, down 24.87% from the prior year.
- Amortizatization of Intangibles for Q1 2026 stood at $2.0 million, up from $2.0 million in the prior quarter.
- The five-year high for Amortizatization of Intangibles was $122.2 million in Q2 2023, with the low at -$88.5 million in Q2 2025.
- Historically, Amortizatization of Intangibles has averaged $7.8 million across 5 years, with a median of $2.9 million in 2024.
- The largest YoY upside for Amortizatization of Intangibles was 199.76% in 2023 against a maximum downside of 260.58% in 2023.
- Tilray Brands' Amortizatization of Intangibles stood at $33.3 million in 2022, then slumped by 91.51% to $2.8 million in 2023, then rose by 3.18% to $2.9 million in 2024, then tumbled by 31.89% to $2.0 million in 2025, then rose by 1.26% to $2.0 million in 2026.
- The last three Amortizatization of Intangibles figures came in at $2.0 million (Q1 2026), $2.0 million (Q4 2025), and $15.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amort. of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | - |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 1.30 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 242,000.00 |
| 10 | Tilray Brands | - | - | 54.95 Mn | 2.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 2.01 Mn |
| Feb 28, 2026 | 2.01 Mn |
| Nov 30, 2025 | 1.99 Mn |
| Nov 30, 2025 | 1.99 Mn |
| Aug 31, 2025 | 15.56 Mn |
| Aug 31, 2025 | 15.56 Mn |
| May 31, 2025 | -88.55 Mn |
| May 31, 2025 | -88.55 Mn |
| Feb 28, 2025 | 2.77 Mn |
| Feb 28, 2025 | 2.77 Mn |
| Nov 30, 2024 | 2.92 Mn |
| Nov 30, 2024 | 2.92 Mn |
| Aug 31, 2024 | 31.81 Mn |
| Aug 31, 2024 | 31.81 Mn |
| May 31, 2024 | -80.72 Mn |
| May 31, 2024 | -80.72 Mn |
| Feb 29, 2024 | 2.90 Mn |
| Feb 29, 2024 | 2.90 Mn |
| Nov 30, 2023 | 2.83 Mn |
| Nov 30, 2023 | 2.83 Mn |